2017—2022年河南省商丘市疑似预防接种异常反应监测分析  

Analysis of adverse events following immunization surveillance in Shangqiu,Henan from 2017 to 2022

作　　者：刘怀印[1] 王明月 LIU Huaiyin;WANG Mingyue(Shangqiu Center for Disease Control and Prevention,Shangqiu,Henan 476100,China)

机构地区：[1]商丘市疾病预防控制中心,河南商丘476100

出　　处：《现代疾病预防控制》2024年第4期265-269,283,共6页MODERN DISEASE CONTROL AND PREVENTION

摘　　要：目的分析2017—2022年河南省商丘市疑似预防接种异常反应(AEFI)的发生特征,评价预防接种的安全性。方法通过中国免疫规划信息管理系统收集2017—2022年商丘市报告的AEFI个案数据,通过河南省免疫规划信息管理系统收集疫苗接种数据,采用描述性流行病学方法进行数据分析。结果商丘市2017—2022年共报告AEFI个案12654例,报告发生率为38.47/10万剂。其中一般反应12477例(占98.60%),报告发生率37.93/10万剂;异常反应104例(占0.82%),报告发生率0.32/10万剂。一般反应中,发热、红肿、硬结12241例,占98.11%。97.94%的AEFI病例病情转归为治愈或好转。结论2017—2022年商丘市AEFI以一般反应为主,病情转归较好,疫苗接种安全性良好。Objective To analyze the occurrence characteristics of adverse event following immunization(AEFI)in Shangqiu city,Henan province from 2017 to 2022,and evaluate the safety of vaccination.Methods The AEFI case data in Shangqiu city from2017 to 2022 were collected through China Information Management System for Immunization Program,and the vaccination data were collected through Henan Provincial Information Management System for Immunization Program.Descriptive epidemiological methods were used to analyze the data.Results A total of 12654 AEFI cases were reported in Shangqiu city from 2017 to 2022,and the reported incidence was 38.47 per 105doses.Of them,12477(98.60%)had general reaction,and the reported incidence was 37.93 per 105doses.There were 104 cases(0.82%)with abnormal reaction,and the reported incidence was 0.32 per 105doses.In general reactions,there were 12241 cases of fever/redness/induration,accounting for 98.11%.Of the AEFI cases,97.95%were cured or improved.Conclusions The reported cases of AEFI in Shangqiu city from 2017 to 2022 were mainly general reactions.The prognosis was good,and the vaccination safety was good.

关 键 词：疑似预防接种异常反应 疫苗 免疫接种 

分 类 号：R186[医药卫生—流行病学]